cervical%20cancer%20-%20prevention%20-and-%20screening
CERVICAL CANCER - PREVENTION & SCREENING
Mortality due to cervical cancer can be reduced by prevention, early detection & treatment.
Vaccination may be started as early as 9 years old.
Vaccination may reduce the incidence of HPV-related disease.
Screening for cervical cancer after vaccination is still recommended because only 70% of the virus types associated w/ invasive cervical cancer consist of HPV 16 & 18 types & women may not be entirely protected if they have been infected w/ other HPV types prior to vaccination.

Cervical%20cancer%20-%20prevention%20-and-%20screening Signs and Symptoms

Introduction

Routine Vaccination

  • Females, 11-12 years of age, are recommended to receive 2 doses of human papilloma virus (HPV) vaccine 6-12 months apart
    • Vaccination may be started as early as 9 years old
  • World Health Organization (WHO) recommends a 2-dose vaccination schedule with a minimum interval of 6 months between doses for females <15 years old
    • For females ≥15 years old and immunocompromised individuals, the 3-dose vaccination schedule is recommended

Catch-Up Dose

  • Females, 13-26 years of age, who have not been previously vaccinated or those who have not completed the doses
    • Those who have not received any previous HPV vaccination should receive a 3-dose vaccine series  
    • Those who have received 2 doses of HPV vaccine at least 5 months apart before the age of 15 years are adequately vaccinated and do not need any additional HPV vaccine dose
    • Those who have received only 1 dose or 2 doses <5 months apart before the age of 15 years are not adequately vaccinated and must receive an additional HPV vaccine dose 
  • HPV exposure risks should be discussed with females 18-45 years old
    • Vaccination would provide full benefit to sexually active females who have not been infected by HPV
    • Less benefit is provided to sexually active females who have been infected by one or more HPV types
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Jairia Dela Cruz, 6 days ago
For inflammatory bowel disease (IBD) patients, smoking cigarettes or just being exposed to secondhand smoke raises the risk of developing colorectal neoplasia, a study has found.
Jairia Dela Cruz, 2 days ago
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.